Instil Bio Current Ratio Growth & History (TIL)
Instil Bio's current ratio was 39.53 for fiscal 2025.
View full Instil Bio company overviewInstil Bio annual current ratio history
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 39.53 | 23.76 | +150.75% |
| 2024 | 2024-12-31 | 15.76 | 0.54 | +3.54% |
| 2023 | 2023-12-31 | 15.22 | 7.01 | +85.31% |
| 2022 | 2022-12-31 | 8.22 | −3.00 | −26.77% |
| 2021 | 2021-12-31 | 11.22 | −7.31 | −39.46% |
| 2020 | 2020-12-31 | 18.53 | — | — |
Instil Bio quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 21.67 | 6.69 | +44.71% |
| Q1 2026 | 2026-03-31 | 39.87 | 9.54 | +31.45% |
| Q4 2025 | 2025-12-31 | 39.53 | 23.76 | +150.75% |
| Q3 2025 | 2025-09-30 | 34.45 | 21.55 | +167.14% |
| Q2 2025 | 2025-06-30 | 14.97 | −0.09 | −0.57% |
| Q1 2025 | 2025-03-31 | 30.33 | 16.14 | +113.80% |
| Q4 2024 | 2024-12-31 | 15.76 | 0.54 | +3.54% |
| Q3 2024 | 2024-09-30 | 12.90 | −1.63 | −11.22% |
| Q2 2024 | 2024-06-30 | 15.06 | 3.05 | +25.44% |
| Q1 2024 | 2024-03-31 | 14.19 | 5.19 | +57.68% |
| Q4 2023 | 2023-12-31 | 15.22 | 7.01 | +85.31% |
| Q3 2023 | 2023-09-30 | 14.53 | 7.08 | +94.99% |
| Q2 2023 | 2023-06-30 | 12.00 | 3.49 | +41.07% |
| Q1 2023 | 2023-03-31 | 9.00 | −1.63 | −15.31% |
| Q4 2022 | 2022-12-31 | 8.22 | −3.00 | −26.77% |
| Q3 2022 | 2022-09-30 | 7.45 | −8.85 | −54.30% |
| Q2 2022 | 2022-06-30 | 8.51 | −15.58 | −64.68% |
| Q1 2022 | 2022-03-31 | 10.62 | −24.80 | −70.01% |
| Q4 2021 | 2021-12-31 | 11.22 | −7.31 | −39.46% |
| Q3 2021 | 2021-09-30 | 16.30 | — | — |
| Q2 2021 | 2021-06-30 | 24.09 | — | — |
| Q1 2021 | 2021-03-31 | 35.43 | — | — |
| Q4 2020 | 2020-12-31 | 18.53 | — | — |
Instil Bio current ratio trends
Over the last five fiscal years, Instil Bio's current ratio increased from 18.53 to 39.53, a change of 20.99. The latest reported quarter, Q2 2026, shows 21.67.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Instil Bio source filings ↗